Khaitan & Co advises Elder Pharmaceuticals on sale of business to Torrent
Khaitan & Co has advised Elder Pharmaceuticals Ltd in relation to the sale of some of Elder’s branded domestic formulations business in India and Nepal to Torrent Pharmaceuticals Ltd by way of a slump sale for a lump sum consideration of $324m (£193m) approximately.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from Khaitan & Co
Briefings from Khaitan & Co
Newsletter: energy, infrastructure and resources — Reserve Bank permits long-term structuring of new long-term project loans to infrastructure and core industries; and more
Khaitan & Co has released the 15 July 2014 edition of its energy, infrastructure and resources newsletter.
The Indian Patent Office has issued guidelines so as to bring about uniformity in the examination of pharmaceutical patent applications.